They should wait for the next several milestones and get more than $8. Lympho by itself is worth $8 once the NDA is approved. RIGS brings multiples of that value if they get CMA approval next year. NEOP is a $25 stock with those two drugs in play. $8 is selling too low when they could triple that by waiting another 18 months imho.